164 related articles for article (PubMed ID: 21638028)
21. miR-219-5p inhibits tau phosphorylation by targeting TTBK1 and GSK-3β in Alzheimer's disease.
Li J; Chen W; Yi Y; Tong Q
J Cell Biochem; 2019 Jun; 120(6):9936-9946. PubMed ID: 30556160
[TBL] [Abstract][Full Text] [Related]
22. Tyrosine 394 is phosphorylated in Alzheimer's paired helical filament tau and in fetal tau with c-Abl as the candidate tyrosine kinase.
Derkinderen P; Scales TM; Hanger DP; Leung KY; Byers HL; Ward MA; Lenz C; Price C; Bird IN; Perera T; Kellie S; Williamson R; Noble W; Van Etten RA; Leroy K; Brion JP; Reynolds CH; Anderton BH
J Neurosci; 2005 Jul; 25(28):6584-93. PubMed ID: 16014719
[TBL] [Abstract][Full Text] [Related]
23. Abnormal Tau phosphorylation of the Alzheimer-type also occurs during mitosis.
Delobel P; Flament S; Hamdane M; Mailliot C; Sambo AV; Bégard S; Sergeant N; Delacourte A; Vilain JP; Buée L
J Neurochem; 2002 Oct; 83(2):412-20. PubMed ID: 12423251
[TBL] [Abstract][Full Text] [Related]
24. Tau-tubulin kinase 1 (TTBK1), a neuron-specific tau kinase candidate, is involved in tau phosphorylation and aggregation.
Sato S; Cerny RL; Buescher JL; Ikezu T
J Neurochem; 2006 Sep; 98(5):1573-84. PubMed ID: 16923168
[TBL] [Abstract][Full Text] [Related]
25. Pseudophosphorylation of tau at serine 422 inhibits caspase cleavage: in vitro evidence and implications for tangle formation in vivo.
Guillozet-Bongaarts AL; Cahill ME; Cryns VL; Reynolds MR; Berry RW; Binder LI
J Neurochem; 2006 May; 97(4):1005-14. PubMed ID: 16606369
[TBL] [Abstract][Full Text] [Related]
26. Tau and Alzheimer's disease: the long road to anti-tangle therapeutics.
Fillit HM; Refolo LM
J Mol Neurosci; 2002 Dec; 19(3):249-50. PubMed ID: 12540049
[No Abstract] [Full Text] [Related]
27. Induction of a specific tau Alzheimer epitope in SY-5Y neuroblastoma cells.
Caillet-Boudin ML; Delacourte A
Neuroreport; 1996 Dec; 8(1):307-10. PubMed ID: 9051801
[TBL] [Abstract][Full Text] [Related]
28. Rho-kinase ROCK inhibitors reduce oligomeric tau protein.
Hamano T; Shirafuji N; Yen SH; Yoshida H; Kanaan NM; Hayashi K; Ikawa M; Yamamura O; Fujita Y; Kuriyama M; Nakamoto Y
Neurobiol Aging; 2020 May; 89():41-54. PubMed ID: 31982202
[TBL] [Abstract][Full Text] [Related]
29. Casein kinase 1 delta phosphorylates tau and disrupts its binding to microtubules.
Li G; Yin H; Kuret J
J Biol Chem; 2004 Apr; 279(16):15938-45. PubMed ID: 14761950
[TBL] [Abstract][Full Text] [Related]
30. Development of a cellular tau enzyme-linked immunosorbent assay method for screening GSK-3β inhibitors.
Cho GW; Noh MY; Kang BY; Ku IW; Park J; Hong YH; Kim MH; Kim SH
Assay Drug Dev Technol; 2011 Oct; 9(5):503-13. PubMed ID: 21561378
[TBL] [Abstract][Full Text] [Related]
31. γ-Aminobutyric acid type A (GABAA) receptor activation modulates tau phosphorylation.
Nykänen NP; Kysenius K; Sakha P; Tammela P; Huttunen HJ
J Biol Chem; 2012 Feb; 287(9):6743-52. PubMed ID: 22235112
[TBL] [Abstract][Full Text] [Related]
32. Activation of Cdk5/p25 and tau phosphorylation following chronic brain hypoperfusion in rats involves microRNA-195 down-regulation.
Sun LH; Ban T; Liu CD; Chen QX; Wang X; Yan ML; Hu XL; Su XL; Bao YN; Sun LL; Zhao LJ; Pei SC; Jiang XM; Zong DK; Ai J
J Neurochem; 2015 Sep; 134(6):1139-51. PubMed ID: 26118667
[TBL] [Abstract][Full Text] [Related]
33. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
34. Multitargeted drug development: Discovery and profiling of dihydroxy substituted 1-aza-9-oxafluorenes as lead compounds targeting Alzheimer disease relevant kinases.
Tell V; Holzer M; Herrmann L; Mahmoud KA; Schächtele C; Totzke F; Hilgeroth A
Bioorg Med Chem Lett; 2012 Nov; 22(22):6914-8. PubMed ID: 23039927
[TBL] [Abstract][Full Text] [Related]
35. Tau acetylation at K280 regulates tau phosphorylation.
Kim MS; Mun YS; Lee SE; Cho WY; Han SH; Kim DH; Yoon SY
Int J Neurosci; 2023 Dec; 133(12):1394-1398. PubMed ID: 35603448
[TBL] [Abstract][Full Text] [Related]
36. An acetylation-phosphorylation switch that regulates tau aggregation propensity and function.
Carlomagno Y; Chung DC; Yue M; Castanedes-Casey M; Madden BJ; Dunmore J; Tong J; DeTure M; Dickson DW; Petrucelli L; Cook C
J Biol Chem; 2017 Sep; 292(37):15277-15286. PubMed ID: 28760828
[TBL] [Abstract][Full Text] [Related]
37. Long non-coding RNA 00507/miRNA-181c-5p/TTBK1/MAPT axis regulates tau hyperphosphorylation in Alzheimer's disease.
Yan Y; Yan H; Teng Y; Wang Q; Yang P; Zhang L; Cheng H; Fu S
J Gene Med; 2020 Dec; 22(12):e3268. PubMed ID: 32891070
[TBL] [Abstract][Full Text] [Related]
38. Acetylsalicylic acid decreases tau phosphorylation at serine 422.
Tortosa E; Avila J; Pérez M
Neurosci Lett; 2006 Mar; 396(1):77-80. PubMed ID: 16386371
[TBL] [Abstract][Full Text] [Related]
39. High-content siRNA screening of the kinome identifies kinases involved in Alzheimer's disease-related tau hyperphosphorylation.
Azorsa DO; Robeson RH; Frost D; Meec hoovet B; Brautigam GR; Dickey C; Beaudry C; Basu GD; Holz DR; Hernandez JA; Bisanz KM; Gwinn L; Grover A; Rogers J; Reiman EM; Hutton M; Stephan DA; Mousses S; Dunckley T
BMC Genomics; 2010 Jan; 11():25. PubMed ID: 20067632
[TBL] [Abstract][Full Text] [Related]
40. Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer's disease and other tauopathies.
Xia Y; Prokop S; Gorion KM; Kim JD; Sorrentino ZA; Bell BM; Manaois AN; Chakrabarty P; Davies P; Giasson BI
Acta Neuropathol Commun; 2020 Jun; 8(1):88. PubMed ID: 32571418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
